Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration-Reference-Cited by-同舟云学术

Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration

Published:2013-07 Issue:1-2 Volume:451 Page:50-56
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Rossi Alessandra,Buttini Francesca,Colombo Paolo,Mor Marco,Pala Daniele,Bortolotti Fabrizio,Colombo Gaia

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference10 articles.

1. Pharmacokinetics of individual components of teicoplanin in man;Bernareggi;J. Pharmacokinet. Biopharm.,1990

2. Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus;Borghi;J. Gen. Microbiol.,1991

3. European Medicines Agency (EMA) – Committee for Medicinal Products for Human Use (CHMP), 2010. Guideline on the investigation of bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1/Corr.

4. Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus;Fujimura;J. Infect. Chemother.,2011

5. Improved quantitative determination of total and unbound concentrations of six teicoplanin components in human plasma by high performance liquid chromatography;Hanada;Biol. Pharm. Bull.,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated identification-quantification (ID-Quant) workflow utilizing UPLC-QTOF-MS for the therapeutic drug monitoring of multi-component antibiotics without pure standards: Validation using teicoplanin;Journal of Chromatography B;2024-06

2. Single-centre retrospective observational study comparing trough blood concentration and safety of teicoplanin formulations;Journal of Infection and Chemotherapy;2019-07

3. About the equivalence between different batches of a glycopeptide drug;Pharmaceutical Development and Technology;2015-04-17

4. Multicomponent antibiotic substances produced by fermentation: Implications for regulatory authorities, critically ill patients and generics;International Journal of Antimicrobial Agents;2014-01